← Human Trials & Peer-Reviewed Studies
[Therapeutic effects of magnesium in dysmenorrhea].
Plain-language guide to PMID 2349410 (1990): double-blind randomized controlled trial of Magnesium in 32 women.
Key Facts
- PMID
- 2349410
- Journal
- Schweizerische Rundschau fur Medizin Praxis = Revue suisse de medecine Praxis
- Year
- 1990
- Study type
- Randomized Controlled Trial
- Authors
- Fontana-Klaiber H et al. (2 authors)
What This Study Did, in Plain Language
What Was Tested
This randomized controlled trial looks at Magnesium.
In a randomized double-blind study, the therapeutic effect of magnesium has been investigated in 32 women (16 to 42 years old) who have been treated in the gynaecological outpatient-department at their clinic because of primary dysmenorrhea.
At the end of the study, which covered six cycles, the researchers were able to analyze the results in 21 patients, 11 having been treated with magnesium and 10 with placebo.
Who Took Part
The abstract describes 32 women taking part.
By PubMed's age tags, the people studied were teenagers and adults, women only.
How the Study Was Run
The researchers set it up as a randomized, double-blind, placebo-controlled, multicenter and parallel-group study.
Random assignment meant chance, not the researchers, decided who got Magnesium and who got the comparison, which limits bias.
As a double-blind Magnesium study, the assignments were hidden from both participants and investigators until the end.
Some women received a placebo instead of Magnesium, giving a reference point.
Running at several centres spread the Magnesium study over different clinics and patient groups.
What Was Measured
In a randomized double-blind study, the therapeutic effect of magnesium has been investigated in 32 women (16 to 42 years old) who have been treated in the gynaecological outpatient-department at their clinic because of primary dysmenorrhea.
PubMed files the paper under topics including Dysmenorrhea and Magnesium.
What This Means in Plain Language
The paper is a randomized, double-blind and placebo-controlled study of Magnesium in 32 women.
With fewer than 40 people, it is a small study, so it is better read as an early signal for further research than as a settled answer.
The publication is from 1990 (Schweizerische Rundschau fur Medizin Praxis = Revue suisse de medecine Praxis), a journal based in Switzerland.
More context: the related Vitamin D, K2, Magnesium and Zinc library page, all human trials.
Related Library Page
Vitamin D, K2, Magnesium and Zinc: Magnesium is described as required for AMPK to function.
Related Pages
Source: PubMed record. This explanation is written by PeptideWhiz from the public record. For research and education only. Not medical advice; no dosing information is given.